Biosynth B.V.

Biosynth® is an innovative life sciences reagents, custom synthesis and manufacturing services company headquartered in Staad, Switzerland. We are by scientists, for scientists, securing supply chains with consistent quality, across the globe. As a trusted supplier, manufacturer and partner to the pharmaceutical, life science and diagnostic industries, as well as food, agrochemical and cosmetic customers, we have facilities on three continents and a rapid global distribution network. Our main production laboratories are located in Switzerland, the UK, Slovakia and China, with peptide and antibody production in the US, the UK and the Netherlands. Enzyme projects are based in Austria, bioconjugation projects in Germany and biological IVD reagents in Ireland.

The Biosynth peptide division (www.biosynth.com/peptides) offers an array of capabilities, from phage display lead discovery to lead-optimization and production facilities for R&D- to GMP-grade peptides, including libraries and neoantigen vaccines. These services are built on proprietary technologies and platforms. Among its patents is the CLIPS™ technology, which locks peptides into their active conformations. It has built unrivalled expertise in complex, constrained, multimeric, and other special peptides.

Biosynth’s custom peptide production uses state-of-the-art instruments at facilities in Lelystad (NL), Gardner (MA, USA) and Louisville (KE, USA). Complex peptides can be produced according to GMP for clinical trials and are always produced at ISO9001 standards.

Biosynth is a member of the Dutch Life Sciences Cooperation, along with four other fast-growing Life Sciences companies.